ACI is currently enrolling patients in a multicenter, randomized, masked, placebo-controlled, clinical trial to evaluate the safety and effectiveness of a potential new treatment for canine chronic inflammatory enteropathy (also known as idiopathic inflammatory bowel disease or IBD). The post Dogs with Chronic Inflammatory Enteropathy appeared first on ACI Biosciences.
